Beyond the hype and the scare stories, how safe are nanoparticles?
Oxford, UK, May 23, 2006 – The May issue of Nano Today launches a dedicated forum for debate on the effects of nanoparticles on human health. In “Nanotechnology: assessing the risks”, Andrew Maynard of the Woodrow Wilson International Center for Scholars calls for a strategic approach to research on potential risks to ensure the development of safe, publicly acceptable nanotechnology products.
Nanotechnology has been touted as the next technology revolution, transforming everything from communications to medicine, water decontamination to homeland security. But scientific progress has been accompanied by fears over unknown consequences of nanotechnology, with one pressure group even calling for a moratorium on all research until more is known. More specific concerns have been voiced by various parties – including the UK Royal Society and Royal Academy of Engineering – about exposure to manufactured nano-sized particles and the possible harmful effects on human health. The future success of nanotechnology will depend on rational and informed work to understand and minimize these potential adverse effects on health and the environment.
“We need to understand both how harmful a substance is, and how much of it can get into the body, if risk is to be understood and managed,” says Maynard. Nanoparticles may have greater reactivity, and so toxicity, than larger sized particles. Because of their size, nanoparticles may also evade some of the body’s natural defense systems and accumulate in some tissues. But currently, there is little information on the impact of engineered nanoparticles, and what there is can be contradictory.
Maynard begins by saying that not all nanomaterials are likely to be of concern. He sets out from the vast range of available nanoscale materials those that are likely to be relevant to human health. Maynard then reviews what has been established about the behavior of nanomaterials in the body, considering how nanoparticles may get into the body via the lungs, skin, or digestive system as well as possible toxic effects.
But risks from even harmful nanoparticles only arise if there has been exposure to a high enough dose. The current picture of how nanomaterials might be released and dispersed in the environment is described in the article, as well as ways of measuring exposure.
“Not only is it necessary to consider the potential for engineered nanomaterials to be released in a form that leads to exposure, chemical and structural transformations between the point of release and the point of exposure will also likely determine health impact,” explains Maynard.
Maynard suggests how potential risks should be managed alongside public awareness of the issues. By providing a context for considering these risks, he is able to suggest directions for further work to ensure the development of safe nanotechnology-based products.
Nano means billionth, so a nanometer is a billionth of a meter. That is clearly very small: on this scale, a human hair is enormous at 100 000 nm across and even red blood cells are thousands of nanometers in diameter. But a DNA molecule, for example, is 2 nm wide. At this level, the properties of materials (electronic, optical, magnetic, etc.) can differ significantly from those at a larger scale, leading to many new possible applications. Nanotechnology is the design and production of materials, devices, and systems at this fundamental, molecular scale.
# # #
About Nano Today
Launched in 2003, Nano Today magazine that reaches over 9000 nanoscience researchers worldwide, providing coverage of the latest research news, science policy matters, reviews of emerging areas, and expert comment and opinion relating to nanoscience.
Notes to Editors:
“Nanotechnology: assessing the risks” appears in the May issue of Nano Today magazine (www.nanotoday.com), which covers current issues in nanotechnology. Highlights from the other articles include:
* While the potential harmful effects of nanoparticles in the environment are often highlighted, one beneficial proposed application is the removal of contaminants from groundwater. Paul G. Tratnyek and Richard L. Johnson from Oregon Health & Science University discuss the benefits and remaining uncertainties of the remediation of contaminated groundwater using nanoparticles containing zero-valent iron (nZVI).
* There are already over 200 products on the market that include nanosized materials or components, according to a recent report. The growing commercialization of products exploiting nanomaterials has been accompanied by increasing calls for regulation. Paula Gould investigates how regulatory bodies are approaching the problems of agreeing measurement standards and regulating exposure to nanoparticles.
* R. P. H. Chang of Northwestern University believes we should make the most of the excitement and novelty surrounding ‘nano’ to spark young people’s interest in science. Certainly, various nanoscience courses have been put together around the world for undergraduates, postgraduates, and even school children. Peter Goodhew of the University of Liverpool, UK looks at how these courses have sought to balance teaching new nano-related material with the basics of conventional science.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai’s Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group plc is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.
Editor, Nano Today
+44 1865 843140